Oppenheimer Asset Management Inc. Sells 366 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Oppenheimer Asset Management Inc. lowered its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,920 shares of the exchange traded fund’s stock after selling 366 shares during the period. Oppenheimer Asset Management Inc.’s holdings in SPDR S&P Biotech ETF were worth $519,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Moors & Cabot Inc. purchased a new stake in SPDR S&P Biotech ETF during the 1st quarter valued at $318,000. Stephens Inc. AR increased its holdings in SPDR S&P Biotech ETF by 17.8% during the 1st quarter. Stephens Inc. AR now owns 11,917 shares of the exchange traded fund’s stock valued at $1,079,000 after purchasing an additional 1,800 shares during the period. Cetera Advisors LLC bought a new position in SPDR S&P Biotech ETF during the 1st quarter valued at approximately $191,000. Blume Capital Management Inc. raised its position in SPDR S&P Biotech ETF by 14.8% during the 1st quarter. Blume Capital Management Inc. now owns 2,330 shares of the exchange traded fund’s stock valued at $211,000 after purchasing an additional 300 shares during the last quarter. Finally, Beaumont Financial Partners LLC bought a new position in SPDR S&P Biotech ETF during the 1st quarter valued at approximately $388,000.

NYSEARCA XBI traded up $0.98 on Wednesday, hitting $82.71. The company’s stock had a trading volume of 333,843 shares, compared to its average volume of 4,630,863. SPDR S&P Biotech ETF has a 52-week low of $64.38 and a 52-week high of $97.60. The company’s 50-day simple moving average is $82.34 and its 200 day simple moving average is $85.46.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Article: The primary rules of Elliott Wave theory

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.